Market Overview

UPDATE: Citigroup Cuts PT to $82 on Thermo Fisher Scientific on In-Line Guidance

Related TMO
Argus: Buy Thermo Fisher On Valuation, Margins
Top Performing Industries For July 22, 2015
Genomics Out Of 'Caveman Era,' But Still A Ways To Go (Investor's Business Daily)

Citigroup maintained Thermo Fisher Scientific (NYSE: TMO) with a Buy rating and lowered the price target from $83.00 to $82.00.

Citigroup noted, "TMO delivered the 4th strong quarter of the year beating on both the top and bottom line driven by strength in Biopharma (similar with WAT) and Healthcare (flu added +30bps to revs). Academic/Gov't and Industrial remained weak but Applied markets continue to perform well with China demonstrating increased appetite for food safety and air quality systems. 2013 guidance was mostly inline though we believe upside may be possible given TMO's expectation for sequestration (NIH budget down -5%)."

Thermo Fisher Scientific closed at $71.11 on Wednesday.

Latest Ratings for TMO

Jul 2015BairdMaintainsOutperform
Jul 2015Leerink SwannMaintainsOutperform
May 2015JP MorganMaintainsOverweight

View More Analyst Ratings for TMO
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Price Target Analyst Ratings


Related Articles (TMO)

View Comments and Join the Discussion!

Get Benzinga's Newsletters